Introducing the new AltIndexLearn more
$2.48B 8.7%Beat EPS +17.8%
Total revenue, Q1 '26 (USD).

Did Biogen Beat Earnings?

Biogen (BIIB) reported Q1 '26 revenue of $2.48B, up 1.9% year-over-year, with reported EPS of $3.57. That topped the $3.03 analyst estimate by 17.8% — an earnings beat.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Biogen’s job postings, web traffic, and employee business outlook. See the full BIIB stock analysis or the earnings calendar for upcoming reports.

BIIB Earnings Surprise History (EPS vs. Estimate)

QuarterEstimated EPSReported EPSSurprise
Q1 '26 $3.03 $3.57 Beat +17.8%
Q4 '25 $1.61 $1.99 Beat +23.6%
Q3 '25 $3.85 $4.81 Beat +24.9%
Q2 '25 $3.88 $5.47 Beat +41.0%
Q1 '25 $2.95 $3.02 Beat +2.4%
Q4 '24 $3.36 $3.44 Beat +2.4%

Biogen Quarterly Financial Trends (USD)

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Revenue2.46B2.47B2.45B2.43B2.65B2.45B2.28B2.48B
Gross margin61.2%74.1%76.2%76.2%64.2%64.3%78.2%73.3%
Operating margin14.9%23.4%20.7%30.1%22.2%25.0%-2.5%16.0%
Net income584M389M267M241M635M467M-48M320M
Net margin23.7%15.8%10.9%9.9%24.0%19.0%-2.1%12.9%
EPS$5.28$4.08$3.44$3.02$5.47$4.81$1.99$3.57

Biogen Earnings Trend Analysis

Over the eight quarters from Q2 '24 to Q1 '26, Biogen’s quarterly revenue moved from $2.46B to $2.48B. Net margin compressed from 23.7% to 12.9%, against a 73.3% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Biogen has beaten Wall Street EPS estimates in 8 of its last 8 reported quarters.

When Is Biogen’s Next Earnings Date?

Biogen reports earnings on a quarterly schedule. Its most recent report covered Q1 '26. For the confirmed upcoming date — and every other company reporting soon — see the BIIB earnings calendar.

Frequently Asked Questions: Biogen Earnings

Biogen's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Biogen reported Q1 '26 EPS of $3.57 on revenue of $2.48B (+1.9% YoY). Biogen beat estimates, reporting $3.57 vs. the $3.03 estimate.

Biogen reported Q1 '26 revenue of $2.48B, up 1.9% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the BIIB AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.